News - Research, Health

Filter

Current filters:

ResearchHealth

Popular Filters

Zydus explores newer treatment options with its breakthrough drug Lipaglyn

Zydus explores newer treatment options with its breakthrough drug Lipaglyn

29-05-2014

Exploring newer therapeutic usage of its breakthrough drug Lipaglyn (saroglitazar), India’s Zydus Group…

DiabetesHealthHealth Medical PharmaIndiaLipaglynLipodystrophyLipodystrophyMetabolicsPharmaceuticalResearchZydus Cadila

Positive top-line results for MedImmune RA and lupus treatments

Positive top-line results for MedImmune RA and lupus treatments

13-05-2014

Anglo-Swedish drug major AstraZeneca has announced that two key molecules in its global biologics R&D…

Anti-Arthritics/RheumaticsAstraZenecaBahija JallalHealthHealth Medical PharmaMajorMedicineMedImmunePharmaceuticalResearchUK

Novartis presents real world data for Lucentis

Novartis presents real world data for Lucentis

09-05-2014

Swiss drug major Novartis has reported data on the eye drug Lucentis (ranibizumab) at the 2014 Association…

AMDEuropeHealthLucentisMajorMedicineNovartisOphthalmicsOphthalmologyPharmaceuticalResearch

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

01-05-2014

French drug major Sanofi and its subsidiary Genzyme presented positive new data from the Lemtrada (alemtuzumab)…

Autoimmune diseasesFranceGenzymeHealthLemtradaMajorMRIMultiple sclerosisNeurologicalPharmaceuticalResearch

AAN 2014: Novartis’ MS drug Gilenya slows brain volume loss

30-04-2014

Data from Swiss drug major Novartis has shown that more patients with relapsing multiple sclerosis treated…

EuropeGilenyaHealthHealth Medical PharmaMedicineMSMultiple sclerosisNeurologicalNovartisPharmaceuticalResearch

Athersys disappointed by Phase II MultiStem study results in UC

29-04-2014

US biotech firm Athersys has announced that interim results from the Phase II clinical study of its MultiStem…

AthersysBiotechnologyChronic, moderate-to-severe UCClinical researchGenito-urinaryHealthMedicineRefractory ulcerative colitisResearchUSA

Potential to fast-track drugs in new Cancer Research UK partnership with AstraZeneca and Pfizer

Potential to fast-track drugs in new Cancer Research UK partnership with AstraZeneca and Pfizer

17-04-2014

British charity Cancer Research UK has joined forces with Anglo-Swedish drug major AstraZeneca and US…

AstraZenecaCancerHealthMajorMedicineOncologyPfizerPharmaceuticalPharmacologyResearchUK

Joint initiative aims to expedite clinical research in Brazil

Joint initiative aims to expedite clinical research in Brazil

14-04-2014

Representatives from universities, scientific research institutions and the pharmaceutical industry created…

BrazilCentral EuropeHealthNational Health Surveillance AgencyPharmaceuticalPharmaceutical industryPharmacologyPoliticsResearch

Back to top